Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

The anticonvulsant topiramate not only decreases ethanol consumption in alcohol dependence (AD) but also may produce several adverse events including cognitive impairment. Zonisamide is a structurally related anticonvulsant that is a promising agent for the treatment of AD and may have greater toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Knapp, Clifford M., Ciraulo, Domenic A., Sarid-Segal, Ofra, Richardson, Mark A., Devine, Eric, Streeter, Chris C., Oscar-Berman, Marlene, Surprise, Caitlin, Colaneri, Laurie, Putnam, Meghan, Waters, Megan, Richambault, Courtney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276485/
https://www.ncbi.nlm.nih.gov/pubmed/25427171
http://dx.doi.org/10.1097/JCP.0000000000000246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276485/
https://www.ncbi.nlm.nih.gov/pubmed/25427171
http://dx.doi.org/10.1097/JCP.0000000000000246

Ejemplares similares